COMPARISON OF THE PSYCHOMETRIC PROPERTIES OF THE SARQOL® QUESTIONNAIRE WITH THE EWGSOP AND EWGSOP2 CRITERIA FOR SARCOPENIA

被引：0
|
作者：
Geerinck, A. [1 ]
Beaudart, C. [1 ]
Reginster, J. -Y. [1 ]
Bruyere, O. [1 ]
机构：
[1] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium
来源：
OSTEOPOROSIS INTERNATIONAL | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC28
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [31] Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
    Dietzel, Roswitha
    Wiegmann, Sabine
    Borucki, Diana
    Detzer, Christian
    Zeiner, Kim Nikola
    Schaumburg, Desiree
    Buehring, Bjoern
    Buttgereit, Frank
    Armbrecht, Gabriele
    [J]. RMD OPEN, 2022, 8 (02):
  • [32] Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
    Chisato Saeki
    Keiko Takano
    Tsunekazu Oikawa
    Yuma Aoki
    Tomoya Kanai
    Kazuki Takakura
    Masanori Nakano
    Yuichi Torisu
    Nobuyuki Sasaki
    Masahiro Abo
    Tomokazu Matsuura
    Akihito Tsubota
    Masayuki Saruta
    [J]. BMC Musculoskeletal Disorders, 20
  • [33] EWGSOP 2010 AND 2019 CRITERIA FOR SARCOPENIA IN ECUADORIAN PATIENTS
    Maldonado, G.
    Intriago, M.
    Guerrero, R.
    Rios, C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S371 - S372
  • [34] EWGSOP 2 VS. EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES
    Locquet, M.
    Beaudart, C.
    Petermans, J.
    Bruyere, O.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S275 - S276
  • [35] EWGSOP1, EWGSOP2 OR SLOWNESS: WHICH IS THE BEST PREDICTOR OF MORTALITY RISK IN OLDER ADULTS?
    Spexoto, M. C. B.
    Ramirez, P. C.
    Maximo, R. O.
    Steptoe, A.
    Oliveira, C.
    Alexandre, T. S.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S224 - S225
  • [36] COMPARISONS OF PREVALENCE OF AND RISK FACTORS FOR SARCOPENIA BY EWGSOP1 AND EWGSOP2 DIAGNOSTIC CRITERIA AMONG COMMUNITY DWELLING OLDER PEOPLE OF IRAN: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
    Shafiee, G.
    Heshmat, R.
    Ostovar, A.
    Sharifi, F.
    Fahimfar, N.
    Gharibzadeh, S.
    Nabipour, I.
    Raeisi, A.
    Larijani, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S555 - S556
  • [37] A translational approach for the clinical application of recently updated definitions of malnutrition (GLIM) and sarcopenia (EWGSOP2)
    Sanchez-Rodriguez, Dolores
    Annweiler, Cedric
    Cederholm, Tommy
    [J]. MATURITAS, 2019, 122 : 89 - 90
  • [38] Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations
    Luz Sanchez-Tocino, M.
    Miranda-Serrano, Blanca
    Gracia-Iguacel, Carolina
    Maria de-Alba-Penaranda, Ana
    Mas-Fontao, Sebastian
    Lopez-Gonzalez, Antonio
    Villoria-Gonzalez, Silvia
    Pereira-Garcia, Monica
    Ortiz, Alberto
    Gonzalez-Parra, Emilio
    [J]. PLOS ONE, 2022, 17 (01):
  • [39] Sarcopenia and associated factors according to the EWGSOP2 criteria in older people living in nursing homes: a cross-sectional study
    Anna Escribà-Salvans
    Javier Jerez-Roig
    Miriam Molas-Tuneu
    Pau Farrés-Godayol
    Pau Moreno-Martin
    Ester Goutan-Roura
    Helena Güell-Masramon
    Jordi Amblàs-Novellas
    Dyego Leandro Bezerra de Souza
    Dawn A. Skelton
    Miriam Torres-Moreno
    Eduard Minobes-Molina
    [J]. BMC Geriatrics, 22
  • [40] Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors
    Emir Celik
    Veysel Suzan
    Nilay Sengul Samanci
    Aysegul Akkan Suzan
    Mehmet Karadag
    Serdar Sahin
    Muhammed Samil Aslan
    Hakan Yavuzer
    Nebi Serkan Demirci
    Alper Doventas
    Fuat Hulusi Demirelli
    [J]. European Geriatric Medicine, 2022, 13 : 267 - 274
12345